Study S002196

Does Glucagon-like Polypeptide 1 Improve Vascular Function and Inflammation?

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT01740921
Acronym: GLP-1ADDS
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Masking: NONE
Status: COMPLETED
Enrollment: 39
Start: 2011-01
Primary completion: 2015-12
Lead sponsor: Royal Devon and Exeter NHS Foundation Trust
Conditions: Type 2 Diabetes
Interventions: DRUG:Liraglutide; OTHER:diet; DRUG:Aspirin
Results posted: FALSE
Secondary identifiers: OTHER:10/H0106/29

Registered primary outcomes

change of baseline skin maximum hyperaemia at 4 months [baseline and 4 months]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0020247	GLP-1 analogue-induced weight loss does not improve obesity-induced AT dysfunction. Pastel E, Clinical science (London, England : 1979)	2017	Randomized trial	PMID 28049736 DOI	registry reference BACKGROUND:28049736